Webster v. Pacesetter, Inc.’s Empirical Analysis
2003
Citation profile
6 district · 1 state decisions
Relationships
Applies 21 U.S.C. § 301 (Animal Drug Amendments of 1968)
Relies on Anderson v. Liberty Lobby, Inc. · Celotex Corporation v. Catrett H · Daubert v. Merrell Dow Pharmaceuticals, Inc. · Buckman Company V.' Legal Committee · Washington Post Company v. US Department of Health and Human Services
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 12 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“Nor can plaintiffs create an issue of fact regarding their defective warning claim by speculating that if the FDA had known of the delayed perforation and tamponade incidents during the clinical trials and if defendant had investigated all the adverse incidents, the FDA would have either recalled the lead or placed it on alert, and therefore, Dr. Lewis would not have implanted it in plaintiff's heart.”
1 later decision quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.